Older therapy is new maintenance option for patients with mesothelioma

While new immunotherapy options are gaining attention in mesothelioma, older chemotherapy treatments such as gemcitabine may still offer benefits for some patients, oncologists say. Results from a Dutch trial of switch-maintenance gemcitabine have shown significant improvement in  progression-free survival  with gemcitabine when used after first-line chemotherapy in patients with unresectable malignant mesothelioma. The phase 2 ...